Trifecta Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Trifecta Capital Advisors's LLY Position: Q3 2026 in Review
Trifecta Capital Advisors held its Eli Lilly (LLY) position steady in Q3 2026 at 25,670 shares worth $29.7M. The position accounts for 3.68% of the portfolio, ranked #6.
Trifecta Capital Advisors first reported a position in LLY in Q4 2022 and has held it in 16 quarters since. The position peaked at $30.8M in Q2 2026. 2,091 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Trifecta Capital Advisors held 25,670 shares of Eli Lilly worth $29.7M as of Q3 2026.
- Trifecta Capital Advisors left its Eli Lilly share count unchanged in Q3 2026.
- Eli Lilly made up 3.68% of Trifecta Capital Advisors's portfolio in Q3 2026, its #6 holding.
- Trifecta Capital Advisors first reported a position in Eli Lilly in Q4 2022 and has held it in 16 quarters since.
- Trifecta Capital Advisors's Eli Lilly position peaked at $30.8M in Q2 2026.
- 2,091 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Trifecta Capital Advisors's 13F filing for Q3 2026, filed 21 Oct 2026.